Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
Clinical trial NCT04526210 · COMPLETED
Trial details
- NCT number
- NCT04526210
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2021-05-28
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.